CeriBell (CBLL) vs Electromed (ELMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CeriBell (CBLL) has outperformed Electromed (ELMD) over the past year, gaining 99.0% versus a gain of 14.4%. CeriBell is the larger company by market cap ($881.9 million vs $227.1 million), about 3.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CBLL | ELMD |
|---|---|---|
| Share price | $22.98 | $27.41 |
| Market cap | $881.93M | $227.15M |
| 1-day change | -2.13% | -2.80% |
| YTD return | +7.07% | -3.16% |
| 1-year return | +98.98% | +14.45% |
| 5-year return | — | +156.60% |
| P/E ratio (TTM) | — | 21.08 |
| Forward P/E | — | 44.93 |
| EPS (TTM) | $-1.76 | $1.30 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $25.63 | $47.40 |
| 52-week low | $10.85 | $23.01 |
| Distance from 52-week high | -10.33% | -42.17% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +24.33% | +76.94% |
| Average volume | 368.86K | 104.76K |
| Shares outstanding | 38.38M | 8.29M |
| Employees | 327 | 195 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CeriBell is about 3.9 times larger than Electromed by market value ($881.93M vs $227.15M).
- CBLL has outperformed ELMD by 84.5 percentage points over the past year.
About CeriBell
CBLL stock →CeriBell, Inc. operates as a medical technology company in the United States.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 327 employees
About Electromed
ELMD stock →Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 195 employees
CBLL vs ELMD FAQ
Which is bigger, CeriBell or Electromed?
CeriBell (CBLL) is larger, with a market capitalization of $881.93M compared with $227.15M for Electromed (ELMD).
Which stock has performed better over the past year, CBLL or ELMD?
CBLL returned +98.98% over the past 12 months, compared with +14.45% for ELMD (price return, excluding dividends). Past performance does not predict future results.
Are CeriBell and Electromed in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.